These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24891295)

  • 1. CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression.
    Gill K; Ariyan C; Wang X; Brady MS; Pulitzer M
    J Surg Oncol; 2014 Sep; 110(3):258-64. PubMed ID: 24891295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30
    Sauder MB; O'Malley JT; LeBoeuf NR
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
    Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
    Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders.
    Liang X; Smoller BR; Golitz LE
    J Cutan Pathol; 2002 Sep; 29(8):459-64. PubMed ID: 12207739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy.
    Querfeld C; Kuzel TM; Guitart J; Rosen ST
    Oncology (Williston Park); 2007 May; 21(6):689-96; discussion 699-700,. PubMed ID: 17564326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
    De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
    J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Kempf W
    Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis.
    Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R
    Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
    Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
    Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel use of 308-nm excimer laser to treat a primary cutaneous CD30+ lymphoproliferative nodule.
    Meisenheimer JL
    J Drugs Dermatol; 2007 Apr; 6(4):440-2. PubMed ID: 17668543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30+ lymphoproliferative disorder with spindle-cell morphology.
    Martires KJ; Cohen BE; Cassarino DS
    J Cutan Pathol; 2016 Nov; 43(11):1041-1044. PubMed ID: 27433975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
    Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
    Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.
    McQuitty E; Curry JL; Tetzlaff MT; Prieto VG; Duvic M; Torres-Cabala C
    J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders.
    Kamstrup MR; Ralfkiaer E; Skovgaard GL; Gniadecki R
    Br J Dermatol; 2008 Apr; 158(4):747-53. PubMed ID: 18241263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent course and CD30 expression of atypical T lymphocytes distinguish lymphomatoid papulosis from primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma.
    Tsujiwaki M; Abe R; Ohguchi Y; Hoshina D; Murata J; Fujita Y; Nomura T; Ambo M; Shimizu H
    Acta Derm Venereol; 2014 Sep; 94(5):613-4. PubMed ID: 24549273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.